APGE Sale Disclosure
Henderson Michael Thomas · SEC Form 4 · Filed Jul 10, 2026
Sale
Calculated transaction value
$2.67M
Henderson Michael Thomas Chief Executive Officer
APGE
Apogee Therapeutics
APGE
Transaction date
Jul 8, 2026
Public filing date
Jul 11, 2026
Filing lag
Filed 3 days later
APGE daily price context
Close on/before transaction
$133.25
Jul 8, 2026
Close before public filing
$133.65
Jul 10, 2026
Return since public filing
+0.9%
Through Aug 25, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 20,000 shares @ $133.63
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001104659-26-082758
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$2.67M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Apogee Therapeutics, Inc. APGE | Gift | Jul 10, 2026 | $0 |
| Apogee Therapeutics, Inc. APGE Current | Sale | Jul 8, 2026 | $2.67M |